Journal Article PreJuSER-62863

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Aggregation and amyloid fibril formation of the prion protein is accelerated in presence of glycogen

 ;  ;  ;  ;  ;  ;  ;

2008
Liebert Larchmont, NY

Rejuvenation research 11, 365 - 369 () [10.1089/rej.2008.0698]

This record in other databases:    

Please use a persistent id in citations: doi:

Abstract: Prion diseases like Creutzfeldt-Jakob disease in humans or scrapie in sheep and goats are infectious neurodegenerative diseases. Their infectious agent, called prion, is composed mainly of aggregated and misfolded prion protein and non-proteinaceous components. An example of such a common non-proteinaceous secondary component of natural prions is the polysaccharide scaffold. We studied the influence of such a polysaccharide on the conformational transition of PrP applying an in vitro conversion system. Here we report that glycogen supports and accelerates PrP amorphous aggregation similar to seeded aggregation and leads to co-aggregates. Furthermore, PrP fibril formation was highly accelerated in the presence of glycogen.

Keyword(s): Amyloid: chemistry (MeSH) ; Animals (MeSH) ; Circular Dichroism (MeSH) ; Cricetinae (MeSH) ; Glycogen: pharmacology (MeSH) ; Mesocricetus (MeSH) ; Prions: chemistry (MeSH) ; Prions: metabolism (MeSH) ; Protein Structure, Quaternary (MeSH) ; Recombinant Proteins: chemistry (MeSH) ; Recombinant Proteins: metabolism (MeSH) ; Amyloid ; Prions ; Recombinant Proteins ; Glycogen ; J

Classification:

Note: Record converted from VDB: 12.11.2012

Contributing Institute(s):
  1. Molekulare Biophysik (INB-2)
Research Program(s):
  1. Funktion und Dysfunktion des Nervensystems (P33)

Appears in the scientific report 2008
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Institute Collections > IBI > IBI-7
Workflow collections > Public records
ICS > ICS-6
Publications database

 Record created 2012-11-13, last modified 2020-04-02



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)